Tumor mutational burden and immune signatures interplay in renal cell carcinoma

被引：17
作者：
Yakirevich, Evgeny
Patel, Nimesh R.
机构：
[1] Brown Univ, Rhode Isl Hosp, Dept Pathol, Providence, RI 02903 USA
[2] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 06期
关键词：
CANCER; LYMPHOCYTES; NEOANTIGENS; ACTIVATION;
D O I：
10.21037/atm.2020.02.81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Using deep learning to predict tumor mutational burden in lung squamous cell carcinoma from 20 centers
    Dammak, Salma
    Cecchini, Matthew J.
    Ward, Aaron D.
    [J]. MEDICAL IMAGING 2022: DIGITAL AND COMPUTATIONAL PATHOLOGY, 2022, 12039
  • [32] Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy development
    Chen, Xinglin
    Zhang, Tongtong
    Zhai, Xinyu
    Wan, Zhong
    Ge, Minyao
    Liu, Chengzong
    Tan, Mingyue
    Xu, Dongliang
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] The correlation of miRNA expression and tumor mutational burden in uterine corpus endometrial carcinoma
    Chen, Yanya
    Wu, Hongyuan
    Zhou, Ruisi
    Dong, Heling
    Zhang, Xuefang
    Wu, Xuewei
    Chen, Wenshan
    You, Yanting
    Wu, Yifen
    [J]. BIOCELL, 2023, 47 (06) : 1353 - 1364
  • [34] A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
    Kourtis, Nikos
    Wang, Qingqing
    Wang, Bei
    Oswald, Erin
    Adler, Christina
    Cherravuru, Samvitha
    Malahias, Evangelia
    Zhang, Lance
    Golubov, Jacquelynn
    Wei, Qiaozhi
    Lemus, Samantha
    Ni, Min
    Ding, Yueming
    Wei, Yi
    Atwal, Gurinder S.
    Thurston, Gavin
    Macdonald, Lynn E.
    Murphy, Andrew J.
    Dhanik, Ankur
    Sleeman, Matthew A.
    Tykodi, Scott S.
    Skokos, Dimitris
    [J]. NATURE CANCER, 2022, 3 (07) : 885 - +
  • [35] Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Burcher, Kimberly M.
    Lantz, Jeffrey W.
    Gavrila, Elena
    Abreu, Arianne
    Burcher, Jack T.
    Faucheux, Andrew T.
    Xie, Amy
    Jackson, Clayton
    Song, Alexander H.
    Hughes, Ryan T.
    Lycan, Thomas, Jr.
    Bunch, Paul M.
    Furdui, Cristina M.
    Topaloglu, Umit
    D'Agostino, Ralph T. B., Jr.
    Zhang, Wei
    Porosnicu, Mercedes
    [J]. CANCERS, 2021, 13 (22)
  • [36] Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
    Jiang, Tao
    Shi, Jinpeng
    Dong, Zhengwei
    Hou, Likun
    Zhao, Chao
    Li, Xuefei
    Mao, Beibei
    Zhu, Wei
    Guo, Xianchao
    Zhang, Henghui
    He, Ji
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Wu, Chunyan
    Zhou, Caicun
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [37] Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinoma
    Wang, Fei
    Xie, Xiaohong
    Song, Mengmeng
    Ji, Liyan
    Liu, Ming
    Li, Pansong
    Guan, Yanfang
    Lin, Xinqing
    Qin, Yinyin
    Xie, Zhanhong
    Zhang, Jiexia
    Ouyang, Ming
    Gu, Yingying
    Deng, Haiyi
    Xia, Xuefeng
    Xin, Yi
    Zhou, Chengzhi
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (12)
  • [38] Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinoma
    Liu, Qi
    Zhao, Shilin
    Su, Pei-Fang
    Yu, Shyr
    [J]. BMC SYSTEMS BIOLOGY, 2013, 7
  • [39] Editorial: Mutational signatures and immune response in cancer
    Georgakopoulos-Soares, Ilias
    Zaravinos, Apostolos
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [40] To be or low TMB (tumor mutational burden)
    Falk, Markus
    Tiemann, Markus
    Ficker, Joachim H.
    Brueckl, Wolfgang M.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02) : 667 - 669
12345